DK

Deepika Kumari

Active Director Director DIN 07510015
DIN 07510015 First appointment May 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2016
Shareholding value •••• Premium profile

About Deepika Kumari

Data last updated:

Deepika Kumari is a Director at Amare Cor Pharmaceuticals Private Limited (since 2016). The company operates in Pharma. Amare Cor Pharmaceuticals Private Limited reported revenue of ₹43.1 Lakh (FY 2024).

DIN 07510015
Primary Designation Director
Industry Pharma
First Appointment 10 May 2016
Oldest Company Age 10 yrs
Largest company Amare Cor Pharmaceuticals Private Limited · ₹43.1 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 May 20162016₹43.1 Lakh (FY 2024)Active

Board colleagues of Deepika Kumari

Directorship timeline

Open interactive timeline →
Amare Cor Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Deepika Kumari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Deepika Kumari

Deepika Kumari currently holds 1 directorship: Amare Cor Pharmaceuticals Private Limited (Director, since 10 May 2016, revenue ₹43.1 Lakh (FY 2024)).

Deepika Kumari was first appointed on 10 May 2016 as Director at Amare Cor Pharmaceuticals Private Limited.

The current boards of Deepika Kumari's companies include Arsh Ranjan (Amare Cor Pharmaceuticals Private Limited), Meghashini (Amare Cor Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available